Laura Shawver - Aug 5, 2022 Form 4 Insider Report for Silverback Therapeutics, Inc. (SPRY)

Role
Chief Executive Officer, Director
Signature
/s/ Jeffrey C. Pepe, Attorney-in-Fact
Stock symbol
SPRY
Transactions as of
Aug 5, 2022
Transactions value $
$100,000
Form type
4
Date filed
8/9/2022, 04:38 PM
Previous filing
Jun 10, 2022
Next filing
May 10, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPRY Common Stock Options Exercise $100K +78.7K +44.87% $1.27 254K Aug 5, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SPRY Stock option (right to buy) Options Exercise $0 -78.7K -16.35% $0.00 403K Aug 5, 2022 Common Stock 78.7K $1.27 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares vested on April 16, 2021 and the remaining shares shall vest in 36 equal monthly installments thereafter.